MiNK Therapeutics, Inc.

INKT · XNAS

CIK 1840229fmd_1VT2THAT8KK19DAXKWVX3X928BManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

Ratios computed from the standardized statements. Select a value to open its proof.